Zentalis Pharmaceuticals, Inc. (ZNTL) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Zentalis Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.71x | -1.30x | -3.39x | -4.50x | -22.61x | -18.09x |
| P/B Ratio | 0.45x | 0.64x | 2.27x | 2.45x | 9.86x | 6.91x |
| P/S Ratio | 0.00x | 3.19x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 100.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | -283.6% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | -246.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | -276.1% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 6.93x | 7.32x | 7.16x | 7.98x | 7.98x | 12.07x |
| Quick Ratio | 6.93x | 7.32x | 7.16x | 7.98x | 7.98x | 12.07x |
| Leverage | ||||||
| Debt/Equity | 0.18x | 0.13x | 0.10x | 0.11x | 0.13x | 0.01x |
YoY = year-over-year change. Source: FMP..